LiJuan Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
LiJuan Zhang has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Haitao Li
Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, People’s Republic of China
1 shared publication- He Li
Neurology Department of The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan City, China
1 shared publication - Hong-Wei Zhi
Affiliated Hospital of Shandong University of traditional Chinese Medicine
1 shared publication Huan Han
The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, 250355, Jinan, China
1 shared publicationJingBo Han
Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China
1 shared publicationKangFeng Wang
Affiliated Hospital of Shandong University of Traditional Chinese Medicine, 250014, Jinan, China
1 shared publication
Latest Publications
- 13 January 2025
- Published by Springer Nature in Inflammation Research
- Vol. 74 (1) , 1-22
Mechanisms of mitochondrial damage-associated molecular patterns associated with inflammatory response in cardiovascular diseases
Cardiovascular diseases (CVDs) continue to be a substantial global healthcare burden despite considerable progress in therapies. The inflammatory response during the progression of CVD has attracted considerable attention. Mitochondria serve as the principal energy source for the heart. In cardiovascular illnesses, mitochondrial homeostasis is disrupted, accompanied by structural and functional impairments. During mitochondrial stress or injury, mitochondrial damage-associated molecular patterns (mtDAMPs), such as mitochondrial DNA, cardiolipin, N-formyl peptide, and adenosine triphosphate, are released to activate pattern recognition receptors and trigger immunological responses. Inflammatory responses mediated by mtDAMPs substantially contribute to the pathophysiology of cardiovascular illnesses. In this review, we discuss the molecular mechanisms by which different mtDAMPs control the inflammatory response, address the pathological consequences of mtDAMPs in inducing or exacerbating the inflammatory response in CVDs, and summarize potential therapeutic targets in relevant experimental studies. Preventing or reducing mtDAMP release may play a role in CVD progression by alleviating the inflammatory response.
- 13 January 2025
- Published by Springer Nature in Inflammation Research
- Vol. 74 (1) , 1-22
Mechanisms of mitochondrial damage-associated molecular patterns associated with inflammatory response in cardiovascular diseases
Cardiovascular diseases (CVDs) continue to be a substantial global healthcare burden despite considerable progress in therapies. The inflammatory response during the progression of CVD has attracted considerable attention. Mitochondria serve as the principal energy source for the heart. In cardiovascular illnesses, mitochondrial homeostasis is disrupted, accompanied by structural and functional impairments. During mitochondrial stress or injury, mitochondrial damage-associated molecular patterns (mtDAMPs), such as mitochondrial DNA, cardiolipin, N-formyl peptide, and adenosine triphosphate, are released to activate pattern recognition receptors and trigger immunological responses. Inflammatory responses mediated by mtDAMPs substantially contribute to the pathophysiology of cardiovascular illnesses. In this review, we discuss the molecular mechanisms by which different mtDAMPs control the inflammatory response, address the pathological consequences of mtDAMPs in inducing or exacerbating the inflammatory response in CVDs, and summarize potential therapeutic targets in relevant experimental studies. Preventing or reducing mtDAMP release may play a role in CVD progression by alleviating the inflammatory response.
- Open Access
Research progress of Ganoderma lucidum polysaccharide in prevention and treatment of Atherosclerosis